跳至主要内容
临床试验/NCT01251263
NCT01251263Unknown4 期

Prevention of Menstrual Migraines: Effects of Estrogen Add-back During the HFI in Patients Using Continuous Oral Contraceptives.

Scott and White Hospital & Clinic1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2010年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
40
试验地点
1
主要终点
Primary Outcome Measure

研究概览

简要总结

This study will examine the combined effects of a continuous oral contraceptive (OC) regimen with supplemental estradiol therapy on headache severity and occurrence in subjects with documented Menstrually Associated Migraines (MAMs). The subjects enrolling in the study will have cyclic menses either due to spontaneous ovulation or use of cyclic hormonal contraception (pill, patch, or ring). Enrolled subjects will start a continuous OC regimen following two baseline menstrual cycles. If breakthrough bleeding/spotting (BTB/BTS) occurs, the subject will institute a 4-day hormone-free interval (HFI). In an attempt to prevent/lessen the severity of headache during the HFI, subjects will be randomized to oral estradiol or placebo during this period. If no BTB/BTS occurs after 80 days of continuous pills, the subject will institute a 4-day HFI during which they will be randomized into estradiol or placebo groups.

The purpose of this research study is to examine the effects of continuous oral contraceptive pills and oral estradiol on headaches that occur around the time of your period. Many woman take continuous oral contraceptive pills (OC) and when OCs are stopped they may get headaches. This study will examine if taking estradiol around the time of the period will affect the headache, and how it will be affected.

This study is a prospective trial. A subject's participation will last approximately 32 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women may be on birth control pill (OC), patch or vaginal ring taken in the traditional 21/7 or 24/4 manner, which means that every month they have a period. If they are taking it continuously (without a period), you must be willing to take your birth control 21/7 for 2 months.
  • If you are not on OC's, patch or vaginal ring you must have a period every 21-40 days.
  • You must not want to get pregnant for 12 months.
  • Women who have headaches around the time of their period.

排除标准

  • If you smoke and are age 35 years old or greater or if you are under 35 years old and smoke over 10 cigarettes a day.
  • If you have or had an aura with your headaches. (An aura is a temporary sensation, like bright lights that come before you experience the headache)
  • Headaches are not occuring during the time of your period.
  • Blood Pressure > 140/90 or you take more than a single antihypertensive medication (excluding diuretics) and are age 40 or greater.
  • Contraindications to combination estrogen/progestin hormonal contraceptives.
  • Desire to become pregnant in the next 12 months.
  • Breast Cancer
  • Blood clots in your legs, lung or anywhere else in your body.
  • Diabetes Mellitus
  • Heart Attack
  • Liver Disease
  • Systemic Lupus Erythematosus

研究组 & 干预措施

Group 1

Other

Cyclic OC users prior to initiating study OC. Estradiol or placebo given in a certain sequence depending on the randomization.

干预措施: Estradiol or Placebo (Drug)

Group 2

Other

Spontaneous ovulation group prior to initiating study OC. Estradiol or placebo given in a certain sequence depending on the randomization.

干预措施: Estradiol or Placebo (Drug)

结局指标

主要结局

Primary Outcome Measure

时间窗: 32 weeks

Comparing baseline menstrually associated migraines(MAMs) to headache occurance and severity after the implementation of continuous OC therapy.

次要结局

  • Secondary Outcome Measure(32 weeks)

研究者

发起方
Scott and White Hospital & Clinic
申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Prevention of Menstrual Migraines: Effects of... | 临床试验